I think this may have been the mouse study Dr. J w
Post# of 148101
https://pubmed.ncbi.nlm.nih.gov/38215963/ CCR5 regulates Aβ1-42-induced learning and memory deficits in mice. I assume that the mice must first develop memory disfunction before they get Leronlimab, or are we going to inject Leronlimab at the beginning of the study to see if it prevents Alzheimer's? I hope it is a study to try to reverse it, but I don't recall the overall goal.